New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For ABT;FB;ALDW;ALJ;LRCX;WES;ABBV;WGP;WHF From The Last 14 Days
Check below for free stories on ABT;FB;ALDW;ALJ;LRCX;WES;ABBV;WGP;WHF the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
August 27, 2014
12:07 EDTFBOn The Fly: Midday Wrap
Subscribe for More Information
10:54 EDTFBFacebook retreats following Janney downgrade
Subscribe for More Information
10:32 EDTFBFacebook slips, levels to watch
The shares are down 1.4% at time of writing to $74.83. Janney Capital earlier downgraded the name to Neutral from Buy, but left their price target unchanged at $82.50. At current price next support is at $73.63. Resistance is at $75.29. Both of those levels are prior pivot points on a closing basis.
10:02 EDTFBActive equity options trading on open
Subscribe for More Information
09:53 EDTFBOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
07:53 EDTFBFacebook LiveRail buy could set up competition with Google, says William Blair
Subscribe for More Information
06:36 EDTFBNordstrom, Target launching Instagram platform, CNBC says
Subscribe for More Information
06:07 EDTFBFacebook downgraded to Neutral from Buy at Janney Capital
Janney Capital downgraded Facebook to Neutral based on valuation and sees headwinds in 2015 from a deceleration in top-line growth, engagement, and monthly active users. Price target remains $82.50.
06:04 EDTFBSnapchat's valuation hits $10B, WSJ reports
Subscribe for More Information
05:54 EDTFBFacebook says did not acquire WaveGroup Sound, VentureBeat reports
Subscribe for More Information
August 26, 2014
11:55 EDTFBInstagram announces Hyperlapse from Instagram app
Instagram announced on its blog Hyperlapse from Instagram, "a new app to capture high-quality time lapse videos even while in motion. Traditionally, time lapse videos depend on holding your phone or camera still while you film. Hyperlapse from Instagram features built-in stabilization technology that lets you create moving, handheld time lapses that result in a cinematic look, quality and feel—a feat that has previously only been possible with expensive equipment." Reference Link
09:35 EDTFBActive equity options trading on open
Subscribe for More Information
August 25, 2014
13:06 EDTFBWhatsApp grows to 600M monthly active users
Subscribe for More Information
August 24, 2014
21:56 EDTLRCXB. Riley to hold a tour
Silicon Valley Tech Tour travels throughout Silicon Valley on August 25-27.
August 21, 2014
15:16 EDTABBVDEA restricts painkiller drug prescriptions to curb abuse, WSJ reports
The Drug Enforcement Agency, or DEA, will reclassify hydrocodone combination painkiller drugs and place them in the category of medical substances that have the highest potential for harm in an attempt to curb the widespread abuse of the drugs, according to The Wall Street Journal. The rescheduling of the drugs will take effect in 45 days and result in people being able to obtain the drug for only 90 days without obtaining a new prescription. Major manufacturers of these drugs include Teva Pharmaceutical (TEVA), Mallinckrodt (MNK), AbbVie (ABBV), and Actavis (ACT). Reference Link
12:59 EDTFBPrivacy lawsuit against Facebook draws support from 60,000 users, Reuters says
A class action lawsuit against Facebook Ireland, the division that runs the company's international business activities, has received support from more than 60,000 users and passed its first legal review, Reuters reports, citing the creator of the lawsuit, Australian law student Max Schrems. The lawsuit claims damages of $663 per Facebook user for alleged privacy violations. The Vienna Regional Court has ordered Facebook Ireland to respond to the claims made by the lawsuit within four weeks, Schrems added. Reference Link
07:57 EDTABBVGilead HCV risks overblown, says Bernstein
Bernstein believes that investors are concerned about upcoming competition to Gilead's (GILD) HCV drug from AbbVie's (ABBV) HCV treatment. But Bernstein says that insurers can only prevent 16% of the U.S. population from receiving Gilead's drug, and the firm does not expect the HCV market share dynamics to change in the near-term. It keeps an Outperform rating on Gilead.
August 20, 2014
09:36 EDTFBActive equity options trading on open
Active equity options trading on open according to Track Data: AAPL FOLD TSLA TWTR WHX FB TM NFLX X EOG
August 19, 2014
09:38 EDTFBActive equity options trading on open
Active equity options trading on open according to Track Data: AAPL GILD TSLA CELG VLO VZ FB HD
07:09 EDTALDWCitigroup to hold a conference
MLP / Midstream Infrastructure Conference to be held in Las Vegas on August 19-21.
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use